Increased expression of mutant forms of p53 oncogene in primary lung cancer
- PMID: 1969059
- DOI: 10.1016/0140-6736(90)90801-b
Increased expression of mutant forms of p53 oncogene in primary lung cancer
Abstract
Primary lung cancer samples of the major histological types were examined for expression of the tumor suppressor gene p53 by immunohistochemistry. Abnormalities in p53 expression were found in 28 of 40 carcinomas, 14 of 17 squamous tumours showing abnormal p53 expression, whereas no expression of p53 was detectable in 7 carcinoid tumours or in 10 normal lung samples. Direct evidence for homozygous expression of mutant p53 mRNA in representative carcinomas was obtained by means of an asymmetric polymerase chain reaction mRNA sequencing strategy, which allowed sequencing without any cloning step. All the mutations were G to T transversions resulting in mis-sense mutations in aminoacids highly conserved in evolution. Mutation of the p53 gene is the most frequently identified genetic change in human lung cancer; these findings suggest that simple immunohistological methods can provide strong evidence of such mutation.
Similar articles
-
p53: a frequent target for genetic abnormalities in lung cancer.Science. 1989 Oct 27;246(4929):491-4. doi: 10.1126/science.2554494. Science. 1989. PMID: 2554494
-
Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.J Clin Invest. 1990 Jul;86(1):363-9. doi: 10.1172/JCI114710. J Clin Invest. 1990. PMID: 2164047 Free PMC article.
-
Mutations in the p53 gene occur in diverse human tumour types.Nature. 1989 Dec 7;342(6250):705-8. doi: 10.1038/342705a0. Nature. 1989. PMID: 2531845
-
[Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].Rinsho Byori. 1996 Jan;44(1):32-41. Rinsho Byori. 1996. PMID: 8691638 Review. Japanese.
-
Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer.Int J Cancer Suppl. 1989;4:32-4. doi: 10.1002/ijc.2910440709. Int J Cancer Suppl. 1989. PMID: 2530182 Review. No abstract available.
Cited by
-
Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma.Cancer Sci. 2024 Sep;115(9):2947-2960. doi: 10.1111/cas.16252. Epub 2024 Jun 21. Cancer Sci. 2024. PMID: 39031627 Free PMC article.
-
p53 mutations in colorectal cancer.Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555-9. doi: 10.1073/pnas.87.19.7555. Proc Natl Acad Sci U S A. 1990. PMID: 1699228 Free PMC article.
-
Low p53 protein expression in salivary gland tumours compared with lung carcinomas.Virchows Arch A Pathol Anat Histopathol. 1992;421(5):415-20. doi: 10.1007/BF01606914. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1333678
-
Altered p53 in microdissected, metachronous, premalignant and malignant oral lesions from the same patients.Clin Mol Pathol. 1995 Oct;48(5):M269-72. doi: 10.1136/mp.48.5.m269. Clin Mol Pathol. 1995. PMID: 16696020 Free PMC article.
-
Increased p53 protein content of colorectal tumours correlates with poor survival.Br J Cancer. 1992 Oct;66(4):758-64. doi: 10.1038/bjc.1992.352. Br J Cancer. 1992. PMID: 1419618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous